XBiotech (STU:4XB) Marketable Securities : €0.00 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is XBiotech Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. XBiotech's Marketable Securities for the quarter that ended in Sep. 2024 was €0.00 Mil.

XBiotech's annual Marketable Securities increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€56.80 Mil) but then declined from Dec. 2022 (€56.80 Mil) to Dec. 2023 (€0.00 Mil).

XBiotech Marketable Securities Historical Data

The historical data trend for XBiotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XBiotech Marketable Securities Chart

XBiotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

56.80

XBiotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

XBiotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

XBiotech (STU:4XB) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

XBiotech Marketable Securities Related Terms

Thank you for viewing the detailed overview of XBiotech's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

XBiotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XBiotech Inc (STU:4XB) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

XBIT:USA

Address

5217 Winnebago Lane, Austin, TX, USA, 78744

Website

http://www.xbiotech.com

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

XBiotech Headlines

No Headlines